Covered recipient · General Payments record
JEFFREY WOOLISCROFT
General Payments · PY2022–2024
$1,912.61
- Reported across 26 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,109.82 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $498.39 | 5 |
| ABBVIE INC. | $260.19 | 8 |
| Sight Sciences, Inc. | $226.24 | 3 |
| Apellis Pharmaceuticals, Inc. | $125.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.67 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106359933 | CMS |
| ABBVIE INC. | $14.84 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106359935 | CMS |
| ABBVIE INC. | $117.65 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106359937 | CMS |
| ABBVIE INC. | $27.52 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106359939 | CMS |
| ABBVIE INC. | $6.78 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106359941 | CMS |
| ABBVIE INC. | $20.85 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106359943 | CMS |
| ABBVIE INC. | $28.56 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106359945 | CMS |
| ABBVIE INC. | $24.32 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106359947 | CMS |
| Alcon Vision LLC | $150.00 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082476251 | CMS |
| Alcon Vision LLC | $129.05 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082476249 | CMS |
| Alcon Vision LLC | $68.63 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082476245 | CMS |
| Alcon Vision LLC | $120.06 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082476247 | CMS |
| Alcon Vision LLC | $30.65 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082476243 | CMS |
| Apellis Pharmaceuticals, Inc. | $125.00 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154022655 | CMS |
| Sight Sciences, Inc. | $67.95 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151926946 | CMS |
| Sight Sciences, Inc. | $24.01 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151926944 | CMS |
| Sight Sciences, Inc. | $134.28 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151926948 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.